Eyepoint Pharmaceuticals (EYPT) USD0.01
Sell:$7.00Buy:$7.44
$0.02
(0.28%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:$7.00
Buy:$7.44
Change:$0.02
(0.28%)
$0.02
(0.28%)Prices delayed by at least 15 minutes
Sell:$7.00
Buy:$7.44
Change:$0.02
(0.28%)
$0.02
(0.28%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 21 August 2024 | Göran Albert Torstensson AndoChairman of the Board | Buy Regular purchase transaction | 5,000 | $7.95 | $39,750.00 | 13,150 |
| 20 August 2024 | Wendy F. DiCiccoIndependent Director | Buy Regular purchase transaction | 2,567 | $7.79 | $19,996.93 | 9,967 |
| 19 August 2024 | Karen L ZaderejIndependent Director | Buy Regular purchase transaction | 12,500 | $7.98 | $99,750.00 | 16,500 |
| 16 August 2024 | Nancy S. LurkerOther Chairman | Buy Regular purchase transaction | 3,173 | $7.88 | $25,003.24 | 97,635 |
| 12 July 2024 | David R. GuyerIndependent Director | Sell Regular sell transaction (market) | 11,625 | $10.06 | $116,995.16 | 1,850 |
| 10 July 2024 | Jay S DukerPresident/COO | Sell Tax related | 8,059 | $8.69 | $70,032.71 | 38,027 |
| 3 June 2024 | David R. GuyerIndependent Director | Sell Regular sell transaction (market) | 11,625 | $10.30 | $119,704.95 | 3,700 |
| 25 May 2024 | George ElstonCFO | Sell Tax related | 3,627 | $11.16 | $40,477.32 | 47,480 |
| 14 May 2024 | David R. GuyerIndependent Director | Sell Regular sell transaction (market) | 11,625 | $12.65 | $147,044.63 | 5,550 |
| 6 May 2024 | CORMORANT ASSET MANAGEMENT LPAsset Management Company | Buy Regular purchase transaction | 207,153 | $12.36 | $2,560,411.08 | 8,325,000 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 11 January 2024 | OCUMENSION THERAPEUTICSOther Legal Entity | Sell Regular sell transaction (market) | 1,910,500 | $19.45 | $37,159,225.00 | 100,221 |
| 11 January 2024 | CORMORANT ASSET MANAGEMENT LPAsset Management Company | Buy Regular purchase transaction | 750,000 | $19.75 | $14,812,500.00 | 6,893,235 |
| 6 May 2024 | CORMORANT ASSET MANAGEMENT LPAsset Management Company | Buy Regular purchase transaction | 642,847 | $11.70 | $7,521,309.90 | 8,117,847 |
| 18 April 2024 | CORMORANT ASSET MANAGEMENT LPAsset Management Company | Buy Regular purchase transaction | 395,244 | $17.62 | $6,964,199.28 | 7,288,479 |
| 18 April 2024 | CORMORANT ASSET MANAGEMENT LPAsset Management Company | Buy Regular purchase transaction | 186,521 | $18.90 | $3,525,246.90 | 7,475,000 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.